List of Aclaris Therapeutics patents

List of Aclaris Therapeutics patents

List of Glasstech patents

List of Owens Corning patents

List of Imagine Optic patents

List of awards received by Jake Gyllenhaal

List of SBIR/STTR awards granted to Hal Technology

Patents where

Current Assignee

Name

is

Aclaris Therapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10098910 Peroxide formulations and methods and applicators for using the same	Patent 10098910 was granted and assigned to Aclaris Therapeutics on October, 2018 by the United States Patent and Trademark Office.	Aclaris Therapeutics	Aclaris Therapeutics		United States Patent and Trademark Office	10098910	October 16, 2018
	‌ US Patent 9675639 Peroxide formulations and methods and applicators for using the same	Patent 9675639 was granted and assigned to Aclaris Therapeutics on June, 2017 by the United States Patent and Trademark Office.	Aclaris Therapeutics	Aclaris Therapeutics		United States Patent and Trademark Office	9675639	June 13, 2017
	‌ US Patent 10335391 Stabilized oxymetazoline formulations and their uses	Patent 10335391 was granted and assigned to Aclaris Therapeutics on July, 2019 by the United States Patent and Trademark Office.	Aclaris Therapeutics	Aclaris Therapeutics		United States Patent and Trademark Office	10335391	July 2, 2019
	‌ US Patent 10981906 Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same	Patent 10981906 was granted and assigned to Aclaris Therapeutics on April, 2021 by the United States Patent and Trademark Office.	Aclaris Therapeutics	Aclaris Therapeutics		United States Patent and Trademark Office	10981906	April 20, 2021
	‌ US Patent 10316038 Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer	Patent 10316038 was granted and assigned to Aclaris Therapeutics on June, 2019 by the United States Patent and Trademark Office.	Aclaris Therapeutics	Aclaris Therapeutics		United States Patent and Trademark Office	10316038	June 11, 2019
	‌ US Patent 10150783 Heterocyclic ITK inhibitors for treating inflammation and cancer	Patent 10150783 was granted and assigned to Aclaris Therapeutics on December, 2018 by the United States Patent and Trademark Office.	Aclaris Therapeutics	Aclaris Therapeutics		United States Patent and Trademark Office	10150783	December 11, 2018
	‌ US Patent 10800775 Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same		Aclaris Therapeutics	Aclaris Therapeutics		United States Patent and Trademark Office	10800775	October 13, 2020
	‌ US Patent 10653721 Peroxide formulations and methods and applicators for using the same	Patent 10653721 was granted and assigned to Aclaris Therapeutics on May, 2020 by the United States Patent and Trademark Office.	Aclaris Therapeutics	Aclaris Therapeutics		United States Patent and Trademark Office	10653721	May 19, 2020
	‌ US Patent 10729720 Peroxide formulations and methods and applicators for using the same	Patent 10729720 was granted and assigned to Aclaris Therapeutics on August, 2020 by the United States Patent and Trademark Office.	Aclaris Therapeutics	Aclaris Therapeutics		United States Patent and Trademark Office	10729720	August 4, 2020
	‌ US Patent 9980983 Peroxide formulations and methods and applicators for using the same	Patent 9980983 was granted and assigned to Aclaris Therapeutics on May, 2018 by the United States Patent and Trademark Office.	Aclaris Therapeutics	Aclaris Therapeutics		United States Patent and Trademark Office	9980983	May 29, 2018
	‌ US Patent 10493103 Peroxide formulations and methods and applicators for using the same	Patent 10493103 was granted and assigned to Aclaris Therapeutics on December, 2019 by the United States Patent and Trademark Office.	Aclaris Therapeutics	Aclaris Therapeutics		United States Patent and Trademark Office	10493103	December 3, 2019
	‌ US Patent 11767309 Methods of synthesizing substituted pyridinone-pyridinyl compounds	Patent 11767309 was granted and assigned to Aclaris Therapeutics on September, 2023 by the United States Patent and Trademark Office.	Aclaris Therapeutics	Aclaris Therapeutics		United States Patent and Trademark Office	11767309	September 26, 2023

12 results

0 selected

12 results

0 selected